Roxanne Dobish

Roxanne Dobish

Auto-generated profile, based on publicly available information

Roxanne Dobish

Alberta Health Services, Calgary, AB, Canada

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 May 2021 in Journal of Oncology Pharmacy Practice
Verified
Journal Article
Closed access
PDF file
Lisa HolleLisa Holle
Lisa Holle
TBTegan Bilse
Tegan Bilse
RARamatu Masud Alabelewe
Ramatu Masud Alabelewe
PKPolly E Kintzel
Polly E Kintzel
EKEsin Aysel Kandemir
Esin Aysel Kandemir
BGBarry R Goldspiel
Barry R Goldspiel
The Oncology Pharmacy Team (OPT), consisting of specialty-trained pharmacists and/or pharmacy technicians, is an integral component of the multidisciplinary healthcare team (MHT) involved with all aspects of cancer patient care. The OPT fosters quality patient care, safety, and local regulatory compliance. The International Society of Oncology Pharmacy Practitioners (ISOPP) developed this position statement to provide guidance on five key areas: 1) oncology pharmacy practice as a pharmacy specialty; 2) contributions to patient care; 3) oncology pharmacy practice management; 4) education and training; and 5) contributions to oncology research and quality initiatives to involve the OPT. This position statement advocates that: 1) the OPT be fully incorporated into the MHT to optimize patient care; 2) educational and healthcare institutions develop programs to continually educate OPT members; and 3) regulatory authorities develop certification programs to recognize the unique contributions of the OPT in cancer patient care.

1 May 2018 in Journal of Oncology Practice
Verified
Journal Article
Open access
RGRachel E. Gilbert
Rachel E. Gilbert
MKMelissa C. Kozak
Melissa C. Kozak
RDRoxanne B. Dobish
Roxanne B. Dobish
VBVenetia C. Bourrier
Venetia C. Bourrier
PKPaul M. Koke
Paul M. Koke
PTPatricia L. Trbovich
Patricia L. Trbovich
Purpose:Intravenous (IV) compounding safety has garnered recent attention as a result of high-profile incidents, awareness efforts from the safety community, and increasingly stringent practice sta...

14 October 2014 in Journal of Oncology Pharmacy Practice
Verified
Journal Article
Open access
RDRoxanne Dobish
Roxanne Dobish
JSJonas Shultz
Jonas Shultz
SNSheena Neilson
Sheena Neilson
ARAmanda Raven
Amanda Raven
CCCarole R Chambers
Carole R Chambers
Following a review of a chemotherapy medication adverse event where the incorrect medication was prepared by a pharmacy, a number of steps were taken to review the literature and best practice information related to checking processes for the preparation of parenteral chemotherapy. Concepts such as identification of critical stop check points, independent double checks, and human factors principles were reviewed and incorporated into newly designed chemotherapy preparation worksheets with embedded checklists. Usability testing and staff feedback during implementation revealed a number of key learning points that resulted in additional work to further improve the chemotherapy worksheets with embedded checklists and highlighted the need for a culture of continuous quality improvement.

18 October 2020 in Journal of Oncology Pharmacy Practice
Verified
Journal Article
Closed access
PDF file
RDRoxanne Dobish
Roxanne Dobish
CBCarol Baumgarten
Carol Baumgarten
FFFrances Folkman
Frances Folkman
CCCarole R Chambers
Carole R Chambers
Medication Reconciliation (MedRec) is an essential part of safe medication management and plays a key role in ensuring patient safety. A variety of methods and a number of different healthcare disciplines can be involved in the MedRec process and the timing and location of conducting MedRec can vary. In an effort to streamline the process in ambulatory oncology new patient clinics, a pilot of an alternative approach was undertaken whereby pharmacists with advanced prescribing privileges completed MedRec with patients prior to their clinic visit. Evaluation of the pilot was completed through the collection of various metrics, a pharmacist focus group, healthcare staff and patient surveys. Overall the evaluation indicated that there are multiple factors to consider regarding the timing and method of MedRec completion. The various phases of the pilot demonstrated that flexibility to the process is key and ongoing efforts are required at reducing duplication.

28 October 2018 in Journal of Oncology Pharmacy Practice
Verified
Journal Article
Closed access
RDRoxanne Dobish
Roxanne Dobish
CCCarole R Chambers
Carole R Chambers
SGSukhraj Gill
Sukhraj Gill
Increasingly stringent pharmacy standards for preparation of sterile products necessitated a review of the feasibility of continuing to maintain chemotherapy sterile production facilities across the provincial cancer programme. The concept of centrally produced chemotherapy that could be shipped to various locations as a remote service delivery model was explored. Key planning principles were established and detailed processes were developed to test this change in service delivery at one small cancer centre. Following the successful implementation and evaluation of the remote service delivery model at one centre, the programme was rolled out to an additional four centres.